{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T13:51:24Z","timestamp":1782481884509,"version":"3.54.5"},"reference-count":51,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ijrobp.2026.01.005","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T07:33:48Z","timestamp":1768635228000},"page":"1059-1070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Critical Role of Dose Homogeneity in Modern Breast Hypofractionation"],"prefix":"10.1016","volume":"125","author":[{"given":"Fady","family":"Sourial","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Champ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4920-4595","authenticated-orcid":false,"given":"Sushil","family":"Beriwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2026.01.005_bib0001","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"Murray Brunt","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0002","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1016\/S0140-6736(23)00619-0","article-title":"Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): A multicentre, phase 3, non-inferiority, open-label, randomised controlled trial","volume":"401","author":"Coles","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0003","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijrobp.2018.08.024","article-title":"Hypofractionated whole-breast irradiation in large-breasted women-is there a dosimetric predictor for acute skin toxicities?","volume":"103","author":"Patel","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0004","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.radonc.2011.01.010","article-title":"Is \u03b1\/\u03b2 for breast cancer really low?","volume":"100","author":"Qi","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0005","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.radonc.2005.03.017","article-title":"The clinical radiobiology of breast cancer radiotherapy","volume":"75","author":"Kurtz","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-8140(87)80213-X","article-title":"The value of the NSD formula in equation of acute and late radiation complications in normal tissue following 2 and 5 fractions per week in breast cancer patients treated with postmastectomy irradiation","volume":"9","author":"Overgaard","year":"1987","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0007","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S1470-2045(06)70699-4","article-title":"Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: Long-term results of a randomised trial","volume":"7","author":"Owen","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0008","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0360-3016(97)00292-7","article-title":"Dosimetric analysis of intact breast irradiation in off-axis planes","volume":"39","author":"Buchholz","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0009","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0360-3016(94)90534-7","article-title":"The effect of the number of computed tomographic slices on dose distributions and evaluation of treatment planning systems for radiation therapy of intact breast","volume":"30","author":"Cheng","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0010","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/0360-3016(89)90545-2","article-title":"Three-dimensional photon dose distributions with and without lung corrections for tangential breast intact treatments","volume":"17","author":"Chin","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0011","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0167-8140(91)90158-D","article-title":"Improved dose homogeneity in the breast using tissue compensators","volume":"22","author":"Mayles","year":"1991","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0012","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0360-3016(91)90178-7","article-title":"Three-dimensional photon treatment planning of the intact breast","volume":"21","author":"Solin","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0013","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0167-8140(99)00072-9","article-title":"An assessment of the number of CT slices necessary to plan breast radiotherapy","volume":"52","author":"Vincent","year":"1999","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0014","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1259\/0007-1285-67-804-1149","article-title":"Invited review: Tangential breast irradiation\u2013Rationale and methods for improving dosimetry","volume":"67","author":"Neal","year":"1994","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0015","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/0167-8140(95)01521-H","article-title":"Correlation of breast dose heterogeneity with breast size using 3D CT planning and dose-volume histograms","volume":"34","author":"Neal","year":"1995","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0016","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0167-8140(94)90063-9","article-title":"The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity","volume":"33","author":"Moody","year":"1994","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0017","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa0906260","article-title":"Long-term results of hypofractionated radiation therapy for breast cancer","volume":"362","author":"Whelan","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0018","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2478\/raon-2018-0026","article-title":"Breast size impact on adjuvant radiotherapy adverse effects and dose parameters in treatment planning","volume":"52","author":"Ratosa","year":"2018","journal-title":"Radiol Oncol"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0019","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.radonc.2016.08.021","article-title":"Ten years results of the Canadian breast intensity modulated radiation therapy (IMRT) randomized controlled trial","volume":"121","author":"Pignol","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0020","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.meddos.2018.01.004","article-title":"Modifiable risk factors for acute skin toxicity in adjuvant breast radiotherapy: Dosimetric analysis and review of the literature","volume":"44","author":"Keenan","year":"2019","journal-title":"Med Dosim"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0021","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ijrobp.2010.09.005","article-title":"Forward intensity-modulated radiotherapy planning in breast cancer to improve dose homogeneity: Feasibility of class solutions","volume":"82","author":"Peulen","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0022","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0360-3016(00)00808-7","article-title":"Dosimetric improvements following 3D planning of tangential breast irradiation","volume":"48","author":"Aref","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0023","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.radonc.2006.12.008","article-title":"Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy","volume":"82","author":"Donovan","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0024","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1200\/JCO.2007.15.2488","article-title":"A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis","volume":"26","author":"Pignol","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0025","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1200\/JCO.2013.49.7842","article-title":"Randomized controlled trial of intensity-modulated radiotherapy for early breast cancer: 5-year results confirm superior overall cosmesis","volume":"31","author":"Mukesh","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0026","article-title":"Volumetric modulated arc therapy for 26 Gy in 5 fractions whole breast irradiation for breast cancer","volume":"10","author":"Choi","year":"2025","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0027","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.ijrobp.2021.09.053","article-title":"Comparative effectiveness analysis of 3D-conformal radiation therapy versus intensity modulated radiation therapy (IMRT) in a prospective multicenter cohort of patients with breast cancer","volume":"112","author":"Jagsi","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0028","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.radonc.2020.09.043","article-title":"Postoperative radiotherapy with intensity-modulated radiation therapy versus 3-dimensional conformal radiotherapy in early breast cancer: A randomized clinical trial of KROG 15-03","volume":"154","author":"Choi","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0029","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","article-title":"The UK standardisation of breast radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials","volume":"14","author":"Haviland","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0030","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1200\/JCO.19.02750","article-title":"Ten-year results of FAST: A randomized controlled trial of 5-fraction whole-breast radiotherapy for early breast cancer","volume":"38","author":"Brunt","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0031","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0140-6736(17)31145-5","article-title":"Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial","volume":"390","author":"Coles","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0032","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1200\/JCO.20.01363","article-title":"Hypofractionated versus standard fractionated radiotherapy in patients with early breast cancer or ductal carcinoma in situ in a randomized phase III trial: The DBCG HYPO trial","volume":"38","author":"Offersen","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0033","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/0284186X.2017.1406140","article-title":"DBCG hypo trial validation of radiotherapy parameters from a national data bank versus manual reporting","volume":"57","author":"Brink","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0034","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.adro.2018.10.005","article-title":"The effect of breast volume on toxicity using hypofractionated regimens for early stage breast cancer for patients","volume":"4","author":"Butler-Xu","year":"2019","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0035","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.1016\/j.ijrobp.2025.07.1302","article-title":"Dosimetric correlates of acute toxicities for hypofractionated whole-breast irradiation, a single institution retrospective investigation: Is there a need to update the guidelines?","volume":"123","author":"Dumane","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0036","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1748-717X-9-97","article-title":"Toxicity and cosmetic outcome of hypofractionated whole-breast radiotherapy: Predictive clinical and dosimetric factors","volume":"9","author":"Ciammella","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0037","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1186\/1471-2407-10-508","article-title":"Predictive factors of radiation-induced skin toxicity in breast cancer patients","volume":"10","author":"Chen","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0038","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/1471-2407-13-230","article-title":"Standard or hypofractionated radiotherapy in the postoperative treatment of breast cancer: A retrospective analysis of acute skin toxicity and dose inhomogeneities","volume":"13","author":"Tortorelli","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0039","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6745954","article-title":"Factors associated with late local radiation toxicity after post-operative breast irradiation","volume":"2022","author":"Batenburg","year":"2022","journal-title":"Breast J"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0040","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0936-6555(05)80657-0","article-title":"Factors affecting acute skin toxicity in patients having breast irradiation after conservative surgery: A prospective study of treatment practice at the Royal Marsden Hospital","volume":"8","author":"Fernando","year":"1996","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0041","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.radonc.2022.09.024","article-title":"Volume matters: Breast induration is associated with irradiated breast volume in the Danish Breast Cancer Group phase III randomized partial breast irradiation trial","volume":"177","author":"Thomsen","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0042","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1470-2045(14)71156-8","article-title":"Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial","volume":"16","author":"Bartelink","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0043","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/annonc\/mds066","article-title":"Long-term cosmetic changes after breast-conserving treatment of patients with stage I-II breast cancer and included in the EORTC 'boost versus no boost\u2019 trial","volume":"23","author":"Immink","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0044","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jmir.2023.05.003","article-title":"Comparison of photon versus electron for tumor bed boost radiotherapy post-breast conserving surgery","volume":"54","author":"Al-Shareef","year":"2023","journal-title":"J Med Imaging Radiat Sci"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0045","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.18.00317","article-title":"Three-year outcomes with hypofractionated versus conventionally fractionated whole-breast irradiation: Results of a randomized, noninferiority clinical trial","volume":"36","author":"Shaitelman","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0046","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.prro.2018.01.012","article-title":"Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline","volume":"8","author":"Smith","year":"2018","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0047","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.ijrobp.2025.05.061","article-title":"Cumulative risk of cosmetic worsening following ultrahypofractionated whole breast radiation therapy with simultaneous integrated boost: The largest real-world data","volume":"123","author":"Wadasadawala","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0048","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ijrobp.2022.07.2320","article-title":"NRG RTOG 1005: A phase III trial of hypo fractionated whole breast irradiation with concurrent boost vs. conventional whole breast irradiation plus sequential boost following lumpectomy for high risk early-stage breast cancer","volume":"114","author":"Vicini","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0049","doi-asserted-by":"crossref","first-page":"e415","DOI":"10.1016\/j.ijrobp.2011.06.1950","article-title":"Prone hypofractionated whole-breast radiotherapy without a boost to the tumor bed: Comparable toxicity of IMRT versus a 3D conformal technique","volume":"82","author":"Hardee","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0050","doi-asserted-by":"crossref","first-page":"7785","DOI":"10.7314\/APJCP.2015.16.17.7785","article-title":"Breast radiotherapy with mixed energy photons; a model for optimal beam weighting","volume":"16","author":"Birgani","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.ijrobp.2026.01.005_bib0051","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/j.prro.2012.01.008","article-title":"Use of intensity modulated radiation therapy to reduce acute and chronic toxicities of breast cancer patients treated with traditional and accelerated whole breast irradiation","volume":"2","author":"Shah","year":"2012","journal-title":"Pract Radiat Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626000751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626000751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T13:26:01Z","timestamp":1782480361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301626000751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0360301626000751"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.01.005","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Critical Role of Dose Homogeneity in Modern Breast Hypofractionation","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}